CYTOMEDIX INC (CMXI) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 98 transactions totaling $1.9M, demonstrating a bullish sentiment with $1.5M in net insider flow. The most recent transaction on Oct 6, 2014 involved a purchase of 33,300 shares valued at $12.0K.
No significant insider buying has been recorded for CMXI in the recent period.
No significant insider selling has been recorded for CMXI in the recent period.
Based on recent SEC filings, insider sentiment for CMXI is bullish with an Insider Alignment Score of 91/100 and a net flow of $1.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at CYTOMEDIX INC (CMXI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading CMXI stock, having executed 98 transactions in the past 90 days. The most active insider is David Emerson Jorden (Executive), who has made 53 transactions totaling $993.6K.
Get notified when executives and directors at CMXI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 6, 2014 | Tozer Dean | Executive | Purchase | 33,300 | $0.36 | $12.0K | |
| Sep 12, 2014 | Tozer Dean | Executive | Purchase | 40,000 | $0.45 | $18.0K | |
| Aug 29, 2014 | Tozer Dean | Executive | Purchase | 40,000 | $0.35 | $14.0K | |
| Aug 26, 2014 | A. Shallcross Steven | Executive | Purchase | 27,500 | $0.38 | $10.4K | |
| Aug 22, 2014 | Tozer Dean | Executive | Purchase | 38,700 | $0.38 | $14.7K | |
| Aug 20, 2014 | A. Shallcross Steven | Executive | Purchase | 52,000 | $0.39 | $20.3K | |
| Aug 20, 2014 | Tozer Dean | Executive | Purchase | 48,000 | $0.39 | $18.7K | |
| Aug 20, 2014 | P. Rosendale Martin | Executive | Purchase | 25,000 | $0.40 | $10.0K | |
| May 21, 2013 | Emerson Jorden David | Executive | Purchase | 55,000 | $0.50 | $27.5K | |
| May 17, 2013 | Emerson Jorden David | Executive | Purchase | 25,000 | $0.50 | $12.5K | |
| Apr 19, 2013 | Emerson Jorden David | Executive | Purchase | 15,000 | $0.50 | $7.5K | |
| Apr 18, 2013 | Emerson Jorden David | Executive | Purchase | 20,000 | $0.51 | $10.2K | |
| Apr 17, 2013 | Emerson Jorden David | Executive | Purchase | 15,000 | $0.51 | $7.7K | |
| Apr 9, 2013 | Emerson Jorden David | Executive | Purchase | 31,515 | $0.52 | $16.4K | |
| Apr 8, 2013 | Emerson Jorden David | Executive | Purchase | 43,485 | $0.51 | $22.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 61 | $1.7M | 77.9% |
Exercise (Options)(X) | 8 | $255.1K | 11.7% |
Sale(S) | 3 | $169.9K | 7.8% |
Other(J) | 21 | $43.1K | 2.0% |
Gift(G) | 1 | $13.2K | 0.6% |
Conversion(C) | 4 | $0 | 0.0% |
Insiders at CYTOMEDIX INC are accumulating shares at an accelerated pace. With 10 insiders making 98 transactions totaling $1.7M in purchases versus $169.9K in sales, the net buying activity of $1.5M signals strong executive confidence. David Emerson Jorden (Executive) leads the buying activity with $993.6K in transactions across all time.